{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:49:55Z","timestamp":1785894595576,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T00:00:00Z","timestamp":1488844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Intramural Research Program of the National Institutes of Health (NIH) National Library of Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13321-017-0200-8","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T09:42:27Z","timestamp":1488879747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Predicting drug\u2013drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge"],"prefix":"10.1186","volume":"9","author":[{"given":"Takako","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"200_CR1","unstructured":"Health, United States, 2014 (5\/2015)\u2014hus14.pdf. \n                    http:\/\/www.cdc.gov\/nchs\/data\/hus\/hus14.pdf\n                    \n                  . Accessed 19 Sep 2016"},{"key":"200_CR2","unstructured":"Research C for DE and drug interactions and labeling\u2014preventable adverse drug reactions: a focus on drug interactions. \n                    http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/DrugInteractionsLabeling\/ucm110632.htm#Types%20of%20Drug%20Interactions\n                    \n                  . Accessed 13 Apr 2016"},{"key":"200_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0553-2","author":"IJ Onakpoya","year":"2016","unstructured":"Onakpoya IJ, Heneghan CJ, Aronson JK (2016) Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. doi:\n                    10.1186\/s12916-016-0553-2","journal-title":"BMC Med"},{"issue":"7","key":"200_CR4","first-page":"601","volume":"18","author":"C Palleria","year":"2013","unstructured":"Palleria C, Di Paolo A, Giofr\u00e8 C et al (2013) Pharmacokinetic drug\u2013drug interaction and their implication in clinical management. J Res Med Sci 18(7):601\u2013610","journal-title":"J Res Med Sci"},{"key":"200_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.03.006","author":"N Ai","year":"2015","unstructured":"Ai N, Fan X, Ekins S (2015) In silico methods for predicting drug\u2013drug interactions with cytochrome P-450s, transporters and beyond. Adv Drug Deliv Rev. doi:\n                    10.1016\/j.addr.2015.03.006","journal-title":"Adv Drug Deliv Rev"},{"key":"200_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/978-3-540-89891-7_29","volume-title":"Drug discovery and evaluation: methods in clinical pharmacology","author":"M Hinder","year":"2011","unstructured":"Hinder M (2011) Pharmacodynamic drug\u2013drug interactions. In: Vogel HG, Maas J, Gebauer A (eds) Drug discovery and evaluation: methods in clinical pharmacology. Springer, Berlin, pp 367\u2013376"},{"key":"200_CR7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1124\/dmd.115.064618","volume":"43","author":"S Yamazaki","year":"2015","unstructured":"Yamazaki S, Johnson TR, Smith BJ (2015) Prediction of drug\u2013drug interactions with Crizotinib as the CYP3A substrate using a physiologically based pharmacokinetic model. Drug Metab Dispos Biol Fate Chem 43:1417\u20131429. doi:\n                    10.1124\/dmd.115.064618","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"200_CR8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/amiajnl-2012-000935","volume":"19","author":"S Vilar","year":"2012","unstructured":"Vilar S, Harpaz R, Uriarte E et al (2012) Drug\u2013drug interaction through molecular structure similarity analysis. J Am Med Inform Assoc JAMIA 19:1066\u20131074. doi:\n                    10.1136\/amiajnl-2012-000935","journal-title":"J Am Med Inform Assoc JAMIA"},{"key":"200_CR9","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/nprot.2014.151","volume":"9","author":"S Vilar","year":"2014","unstructured":"Vilar S, Uriarte E, Santana L et al (2014) Similarity-based modeling in large-scale prediction of drug\u2013drug interactions. Nat Protoc 9:2147\u20132163. doi:\n                    10.1038\/nprot.2014.151","journal-title":"Nat Protoc"},{"key":"200_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2012.26","author":"A Gottlieb","year":"2012","unstructured":"Gottlieb A, Stein GY, Oron Y et al (2012) INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol Syst Biol. doi:\n                    10.1038\/msb.2012.26","journal-title":"Mol Syst Biol"},{"key":"200_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2174\/138920021505141126102223","volume":"15","author":"S Vilar","year":"2014","unstructured":"Vilar S, Uriarte E, Santana L et al (2014) State of the art and development of a drug\u2013drug interaction large scale predictor based on 3D pharmacophoric similarity. Curr Drug Metab 15:490\u2013501","journal-title":"Curr Drug Metab"},{"key":"200_CR12","doi-asserted-by":"publisher","first-page":"W46","DOI":"10.1093\/nar\/gku433","volume":"42","author":"H Luo","year":"2014","unstructured":"Luo H, Zhang P, Huang H et al (2014) DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome. Nucleic Acids Res 42:W46\u2013W52. doi:\n                    10.1093\/nar\/gku433\n                    \n                  .","journal-title":"Nucleic Acids Res"},{"key":"200_CR13","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1136\/amiajnl-2013-002512","volume":"21","author":"F Cheng","year":"2014","unstructured":"Cheng F, Zhao Z (2014) Machine learning-based prediction of drug\u2013drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J Am Med Inform Assoc 21:e278\u2013e286. doi:\n                    10.1136\/amiajnl-2013-002512","journal-title":"J Am Med Inform Assoc"},{"key":"200_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1021\/acs.molpharmaceut.5b00762","volume":"13","author":"AV Zakharov","year":"2016","unstructured":"Zakharov AV, Varlamova EV, Lagunin AA et al (2016) QSAR modeling and prediction of drug\u2013drug interactions. Mol Pharm 13:545\u2013556. doi:\n                    10.1021\/acs.molpharmaceut.5b00762","journal-title":"Mol Pharm"},{"key":"200_CR15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5b00119","author":"M Herrero-Zazo","year":"2015","unstructured":"Herrero-Zazo M, Segura-Bedmar I, Hastings J, Mart\u00ednez P (2015) DINTO: using OWL ontologies and SWRL rules to infer drug\u2013drug interactions and their mechanisms. J Chem Inf Model. doi:\n                    10.1021\/acs.jcim.5b00119","journal-title":"J Chem Inf Model"},{"key":"200_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep07160","author":"H Huang","year":"2014","unstructured":"Huang H, Zhang P, Qu XA et al (2014) Systematic prediction of drug combinations based on clinical side-effects. Sci Rep. doi:\n                    10.1038\/srep07160","journal-title":"Sci Rep"},{"key":"200_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061468","author":"A Cami","year":"2013","unstructured":"Cami A, Manzi S, Arnold A, Reis BY (2013) Pharmacointeraction network models predict unknown drug\u2013drug interactions. PLoS ONE. doi:\n                    10.1371\/journal.pone.0061468","journal-title":"PLoS ONE"},{"key":"200_CR18","doi-asserted-by":"publisher","first-page":"12339","DOI":"10.1038\/srep12339","volume":"5","author":"P Zhang","year":"2015","unstructured":"Zhang P, Wang F, Hu J, Sorrentino R (2015) Label propagation prediction of drug\u2013drug interactions based on clinical side effects. Sci Rep 5:12339. doi:\n                    10.1038\/srep12339","journal-title":"Sci Rep"},{"key":"200_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/amiajnl-2013-001612","volume":"21","author":"SV Iyer","year":"2014","unstructured":"Iyer SV, Harpaz R, LePendu P et al (2014) Mining clinical text for signals of adverse drug\u2013drug interactions. J Am Med Inform Assoc 21:353\u2013362. doi:\n                    10.1136\/amiajnl-2013-001612","journal-title":"J Am Med Inform Assoc"},{"key":"200_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40264-015-0352-2","volume":"39","author":"JM Banda","year":"2015","unstructured":"Banda JM, Callahan A, Winnenburg R et al (2015) Feasibility of prioritizing drug\u2013drug-event associations found in electronic health records. Drug Saf 39:45\u201357. doi:\n                    10.1007\/s40264-015-0352-2","journal-title":"Drug Saf"},{"key":"200_CR21","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1021\/mp900132e","volume":"6","author":"L Zhang","year":"2009","unstructured":"Zhang L, Zhang Y, Huang S-M (2009) Scientific and regulatory perspectives on metabolizing enzyme\u2013transporter interplay and its role in drug interactions: challenges in predicting drug interactions. Mol Pharm 6:1766\u20131774. doi:\n                    10.1021\/mp900132e","journal-title":"Mol Pharm"},{"key":"200_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1124\/pr.110.002584","volume":"63","author":"RAB Waterschoot van","year":"2011","unstructured":"van Waterschoot RAB, Schinkel AH (2011) A Critical analysis of the interplay between Cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice. Pharmacol Rev 63:390\u2013410. doi:\n                    10.1124\/pr.110.002584","journal-title":"Pharmacol Rev"},{"key":"200_CR23","unstructured":"WHO Model List of Essential Medicine. \n                    http:\/\/www.who.int\/selection_medicines\/committees\/expert\/20\/EML_2015_FINAL_amended_AUG2015.pdf?ua=1\n                    \n                  . Accessed 28 April 2016"},{"key":"200_CR24","unstructured":"Drug Interactions results\u2014MICROMEDEX\u00ae. \n                    http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/PFDefaultActionId\/evidencexpert.ShowDrugInteractionsResults\n                    \n                  . Accessed 9 May 2016"},{"key":"200_CR25","unstructured":"Quercetin Drug Interactions\u2014Drugs.com. \n                    http:\/\/www.drugs.com\/drug-interactions\/bioflavonoids,quercetin.html\n                    \n                  . Accessed 4 May 2016"},{"key":"200_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/chir.20794","volume":"22","author":"L Bari Di","year":"2010","unstructured":"Di Bari L, Ripoli S, Pradhan S, Salvadori P (2010) Interactions between quercetin and warfarin for albumin binding: a new eye on food\/drug interference. Chirality 22:593\u2013596. doi:\n                    10.1002\/chir.20794","journal-title":"Chirality"},{"key":"200_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1742-4658.2005.05071.x","volume":"273","author":"HG Mahesha","year":"2006","unstructured":"Mahesha HG, Singh SA, Srinivasan N, Rao AGA (2006) A spectroscopic study of the interaction of isoflavones with human serum albumin. FEBS J 273:451\u2013467. doi:\n                    10.1111\/j.1742-4658.2005.05071.x","journal-title":"FEBS J"},{"key":"200_CR28","unstructured":"Dronabinol: MedlinePlus Drug Information. https:\n                    https:\/\/www.nlm.nih.gov\/medlineplus\/druginfo\/meds\/a607054.html\n                    \n                  . Accessed 3 May 2016"},{"key":"200_CR29","unstructured":"Lovastatin and simvastatin\/sitagliptin Drug Interactions\u2014Drugs.com. \n                    http:\/\/www.drugs.com\/drug-interactions\/lovastatin-with-simvastatin-sitagliptin-1492-0-3347-0.html?professional=1\n                    \n                  . Accessed 4 May 2016"},{"key":"200_CR30","unstructured":"Prednisolone and simvastatin\/sitagliptin Drug Interactions\u2014Drugs.com. \n                    http:\/\/www.drugs.com\/drug-interactions\/prednisolone-with-simvastatin-sitagliptin-1933-0-3347-0.html?professional=1\n                    \n                  . Accessed 4 May 2016"},{"key":"200_CR31","unstructured":"Dexamethasone and simvastatin\/sitagliptin Drug Interactions\u2014Drugs.com. \n                    http:\/\/www.drugs.com\/drug-interactions\/dexamethasone-with-simvastatin-sitagliptin-810-0-3347-0.html?professional=1\n                    \n                  . Accessed 4 May 2016"},{"key":"200_CR32","unstructured":"Prednisone and simvastatin\/sitagliptin Drug Interactions\u2014Drugs.com. \n                    http:\/\/www.drugs.com\/drug-interactions\/prednisone-with-simvastatin-sitagliptin-1936-0-3347-0.html?professional=1\n                    \n                  . Accessed 4 May 2016"},{"key":"200_CR33","unstructured":"Simvastatin\/sitagliptin and tacrolimus Drug Interactions\u2014Drugs.com. \n                    http:\/\/www.drugs.com\/drug-interactions\/simvastatin-sitagliptin-with-tacrolimus-3347-0-2142-0.html?professional=1\n                    \n                  . Accessed 4 May 2016"},{"key":"200_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1211\/0022357021778493","volume":"54","author":"T Sakaeda","year":"2002","unstructured":"Sakaeda T, Takara K, Kakumoto M et al (2002) Simvastatin and lovastatin, but not pravastatin, interact with MDR1. J Pharm Pharmacol 54:419\u2013423","journal-title":"J Pharm Pharmacol"},{"key":"200_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0035-1569375","volume":"124","author":"R Krysiak","year":"2016","unstructured":"Krysiak R, Kowalcze K, Bednarska-Czerwi\u0144ska A, Okopie\u0144 B (2016) The effect of simvastatin on plasma steroid hormone levels in wetformin-treated women with non-classic congenital adrenal hyperplasia. Exp Clin Endocrinol Diabetes 124:215\u2013219. doi:\n                    10.1055\/s-0035-1569375","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"200_CR36","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2174\/13816128113199990467","volume":"20","author":"Y Lai","year":"2014","unstructured":"Lai Y, Hsiao P (2014) Beyond the ITC white paper: emerging sciences in drug transporters and opportunities for drug development. Curr Pharm Des 20:1577\u20131594","journal-title":"Curr Pharm Des"},{"key":"200_CR37","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC et al (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:D668\u2013D672. doi:\n                    10.1093\/nar\/gkj067","journal-title":"Nucleic Acids Res"},{"key":"200_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/clpt.2012.96","volume":"92","author":"M Whirl-Carrillo","year":"2012","unstructured":"Whirl-Carrillo M, McDonagh EM, Hebert JM et al (2012) Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92:414\u2013417. doi:\n                    10.1038\/clpt.2012.96","journal-title":"Clin Pharmacol Ther"},{"key":"200_CR39","doi-asserted-by":"publisher","first-page":"D535","DOI":"10.1093\/nar\/gkj109","volume":"34","author":"C Stark","year":"2006","unstructured":"Stark C, Breitkreutz B-J, Reguly T et al (2006) BioGRID: a general repository for interaction datasets. Nucleic Acids Res 34:D535\u2013D539. doi:\n                    10.1093\/nar\/gkj109","journal-title":"Nucleic Acids Res"},{"key":"200_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/clpt.2009.42","volume":"86","author":"NT Hansen","year":"2009","unstructured":"Hansen NT, Brunak S, Altman RB (2009) Generating genome-scale candidate gene lists for pharmacogenomics. Clin Pharmacol Ther 86:183\u2013189. doi:\n                    10.1038\/clpt.2009.42","journal-title":"Clin Pharmacol Ther"},{"key":"200_CR41","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE et al (2016) PubChem substance and compound databases. Nucleic Acids Res 44:D1202\u2013D1213. doi:\n                    10.1093\/nar\/gkv951","journal-title":"Nucleic Acids Res"},{"key":"200_CR42","unstructured":"M Kuhn (2015) Contributions from J. Wing, S. Weston, A. Williams, C. Keefer, A. Engelhardt, T. Cooper, Z. Mayer, B. Kenkel, the R Core Team, M. Benesty, R. Lescarbeau, A. Ziem and L. Scrucca. caret: Classification and regression training. R package version 6.0-41"},{"key":"200_CR43","unstructured":"R Core Team (2013) R: A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. \n                    http:\/\/www.R-project.org\/"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-017-0200-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-017-0200-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-017-0200-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T13:42:47Z","timestamp":1561383767000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-017-0200-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1186\/s13321-017-0200-8","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]},"assertion":[{"value":"9 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"16"}}